RETATRUTIDE 20mg

Retatrutide is a novel triple agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. One of the most advanced compounds under investigation for metabolic regulation and cardiometabolic health research, this 20mg formulation provides extended research volume for longitudinal metabolic and weight management studies.

• Metabolic & weight management research peptide

• GLP-1/GIP/glucagon triple receptor agonism studies

Specifications

• Form: Lyophilized powder

• Content: 20mg per vial

• Purity: ≥99% (HPLC verified)

• Storage: Refrigerate or store in a cool, dry place

• Third-party lab tested. COA available on request.

Best stacks with: Tesamorelin, Semaglutide, AOD-9604